MGTA - Magenta Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $16.2. This is a potential upside of $2.98 (22.54%) from yesterday's end of day stock price of $13.22.

Magenta Therapeutics's activity chart (see below) currently has 5 price targets and 9 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 33.33% with an average time for these price targets to be met of 110 days.

Most recent stock forecast was given by DAVID NIERENGARTEN from WEDBUSH on 26-Jan-2023. First documented stock forecast 16-Jul-2018.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$1

$0.3 (42.86%)

$9

2 years 2 months 30 days ago
(26-Jan-2023)

0/4 (0%)

$0.56 (127.27%)

Hold

$3

2 years 2 months 30 days ago
(26-Jan-2023)

2/3 (66.67%)

$-2.8 (-48.28%)

266

Hold

$2

$1.3 (185.71%)

$7

2 years 8 months ago
(25-Aug-2022)

1/3 (33.33%)

$0.13 (6.95%)

14

Buy

$8

$7.3 (1042.86%)

$17

3 years 7 days ago
(18-Apr-2022)

0/3 (0%)

$6.08 (316.67%)

Buy

$8

$7.3 (1042.86%)

$17

3 years 11 days ago
(14-Apr-2022)

0/2 (0%)

$5.76 (257.14%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is MGTA (Magenta Therapeutics) average time for price targets to be met?

On average it took 110 days on average for the stock forecasts to be realized with a an average price target met ratio 33.33

Which analyst has the current highest performing score on MGTA (Magenta Therapeutics) with a proven track record?

YUN ZHONG

Which analyst has the current lower performing score on MGTA (Magenta Therapeutics) with a proven track record?

VAMIL DIVAN

Which analyst has the most public recommendations on MGTA (Magenta Therapeutics)?

Yun Zhong works at WEDBUSH and has 12 price targets and 8 ratings on MGTA

Which analyst is the currently most bullish on MGTA (Magenta Therapeutics)?

Vamil Divan with highest potential upside - $7.3

Which analyst is the currently most reserved on MGTA (Magenta Therapeutics)?

Jessica Fye with lowest potential downside - -$6.22

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?